Skip to main content

Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances

Completed · Phase 3 · NCT06349759

Conditions: Mesopic Vision, Night Vision Loss

At a glance

Research payments reported, 2025
$3.4M
U.S. investigators named
38
Sites paid
41
Planned or actual enrollment
200

About the trial

Sponsor
Opus Genetics, Inc (with Viatris Inc.)
Tested
phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist (drug), Placebo (drug)
Dates
Started 2024-04-01; completion 2026-02-19
Results posted
Yes

Safety and efficacy of 0.75% Phentolamine Ophthalmic Solution to improve mesopic low contrast visual acuity in subjects with post-refractive surgery visual disturbances.

From ClinicalTrials.gov, last updated 2026-10-26. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Oyster Point Pharma, Inc. reported $3.4M in research payments for this study in 2025 (310 payments).

Products named: Ryzumvi

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Eye Doctors of Arizona $423,038
  • Eye Research Foundation, Inc $378,506
  • Global Research Management Inc $329,146
  • Total Eye Care, PA $283,144
  • Arizona Eye Center $242,333
  • Segal Drug Trials, Inc $164,619
  • Oculus Research, Inc. $142,553
  • Red River Research PArtners $119,361
  • Sabal Eye Care $115,288
  • Gordon Schanzlin New Vision Institute $113,414
  • Shettle Eye Research, Inc. $104,354
  • West Bay Eye Associates $91,754
  • Mrb Eye Consultants, LLC $83,116
  • Moyes Eye Center $77,986
  • Kannar Eye Center $77,230
  • Fraser Eye Care Center $70,097
  • Price Vision Group $66,148
  • Durrie Vision $58,172
  • Optometry Group PLLC $55,957
  • Rochester Ophthalmological Group $55,200
  • Carrot Eye Center $55,086
  • Pnv Clinical Research LLC $53,736
  • Advance Vision Research LLC $33,451
  • Mid Florida Eye Center, P.a. $24,319
  • Levenson Eye Associates $23,838
  • Athens Eye Care $23,787
  • Lake Travis Eye and Laser Center / Revolution Research $17,966
  • Heart of America Eye Care, P.a $16,288
  • Piedmont Eye Center $14,660
  • Bergstrom Eye Research $9,918
  • Lobue Laser and Eye Medical Center, Inc. $9,510
  • The Eye Institute $9,432
  • Butchertown Clinical Trials $8,395
  • Eye Research Foundation $7,284
  • Wolstan & Goldberg Eye Associates $6,866
  • Oculus Research $6,198
  • Hoopes, Durrie, Rivera Research $1,496
  • Empire Eye and Laser Center $1,452
  • Center for Ophthalmic and Vision Research $1,200
  • International Research Center $790
  • Bowden Eye & Associates $600

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.